Switch to:
More From Other Websites
EXELIXIS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters... May 26 2016
Exelixis' Kidney Cancer Drug Cabometyx Positive in Phase II May 24 2016
Ipsen’s partner Exelixis announced results from randomized phase 2 trial CABOSUN that demonstrate... May 23 2016
Exelixis Announces Results from Randomized Phase 2 Trial CABOSUN Demonstrate Cabozantinib... May 23 2016
Exelixis Announces Results from Randomized Phase 2 Trial CABOSUN Demonstrate Cabozantinib... May 23 2016
XBI and IHI Rose despite the Biotechnology Sector’s Sluggish Week May 16 2016
Exelixis (EXEL) Worth a Look: Stock Up 8.1% in Session May 16 2016
EXELIXIS, INC. Financials May 12 2016
ETF’s with exposure to Exelixis, Inc. : May 11, 2016 May 11 2016
Exelixis, Inc. :EXEL-US: Earnings Analysis: Q1, 2016 By the Numbers May 09 2016
Exelixis to Present at the Bank of America Merrill Lynch 2016 Health Care Conference on May 10 May 05 2016
Exelixis to Present at the Bank of America Merrill Lynch 2016 Health Care Conference on May 10 May 05 2016
Exelixis (EXEL) Reports Wider-than-Expected Loss in Q1 May 05 2016
3 Big Pharma Stocks With Credible Threats to Their Blockbusters May 05 2016
Edited Transcript of EXEL earnings conference call or presentation 4-May-16 9:00pm GMT May 05 2016
Exelixis reports 1Q loss May 04 2016
Exelixis reports 1Q loss May 04 2016
Exelixis Inc Earnings Call scheduled for 5:00 pm ET today May 04 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK